×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
THE STATE KEY LA... [2]
Institute of Chi... [1]
Faculty of Healt... [1]
Authors
Document Type
Journal article [3]
Date Issued
2021 [1]
2020 [1]
2019 [1]
Language
英語English [3]
Source Publication
Biomedicine and ... [1]
International Im... [1]
PHARMACOLOGICAL ... [1]
Indexed By
SCIE [2]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-3 of 3
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways
Journal article
Dou, Yaoxing, Huang, Ronglei, Li, Qiaoping, Liu, Yuhong, Li, Yucui, Chen, Hanbin, Ai, Gaoxiang, Xie, Jianhui, Zeng, Huifang, Chen, Jiannan, Luo, Chaodan, Su, Ziren. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways[J]. Biomedicine and Pharmacotherapy, 2021, 137, 111312.
Authors:
Dou, Yaoxing
;
Huang, Ronglei
;
Li, Qiaoping
;
Liu, Yuhong
;
Li, Yucui
; et al.
Favorite
|
TC[WOS]:
56
TC[Scopus]:
58
IF:
6.9
/
6.8
|
Submit date:2021/12/08
Berberine
Diabetes
Metabolite
Oxidative Stress And Inflammation
Oxyberberine
Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway
Journal article
Cailan Li, Gaoxiang Ai, Yongfu Wang, Qiang Lu, Chaodan Luo, Lihua Tan, Guosheng Lin, Yuhong Liu, Yucui Li, Huifang Zeng, Jiannan Chen, Zhixiu Lin, Yanfang Xian, Xiaoqi Huang, Jianhui Xie, Ziren Su. Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway[J]. PHARMACOLOGICAL RESEARCH, 2020, 152.
Authors:
Cailan Li
;
Gaoxiang Ai
;
Yongfu Wang
;
Qiang Lu
;
Chaodan Luo
; et al.
Favorite
|
TC[WOS]:
178
TC[Scopus]:
195
IF:
9.1
/
9.0
|
Submit date:2021/12/06
Gut Microflora
Intestinal Epithelial Barrier
Metabolite
Oxyberberine
Tlr4-myd88-nf-κb
Ulcerative Colitis
Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways
Journal article
Tan, L., Wang, Yongfu, Ai, Gaoxiang, Luo, Chaodan, Chen, Hanbin, Li, Cailan, Zeng, Huifang, Xie, Jianhui, Chen, Jiannan, Su, Z.. Dihydroberberine, a hydrogenated derivative of berberine firstly identified in Phellodendri Chinese Cortex, exerts anti-inflammatory effect via dual modulation of NF-κB and MAPK signaling pathways[J]. International Immunopharmacology, 2019, 75.
Authors:
Tan, L.
;
Wang, Yongfu
;
Ai, Gaoxiang
;
Luo, Chaodan
;
Chen, Hanbin
; et al.
Favorite
|
TC[WOS]:
23
TC[Scopus]:
29
IF:
4.8
/
5.0
|
Submit date:2022/05/17
Anti-inflammatory
Dihydroberberine
Inflammatory Mediators
Mapk
Nf-κb
Phellodendri Chinese Cortex